Osteoarthritis
Stem cell ‘pain sponge’ therapy shows promise for osteoarthritis relief and joint protection
Raportoinut AI AI:n luoma kuva Faktatarkistettu
SereNeuro Therapeutics has reported promising preclinical data for SN101, an induced pluripotent stem cell-based therapy for chronic osteoarthritis pain. The treatment uses engineered peripheral pain-sensing neurons that sequester inflammatory pain factors without transmitting pain signals, while releasing regenerative molecules that may help preserve cartilage, according to data presented at an International Society for Stem Cell Research symposium.
An umbrella review and pooled analysis published in BMJ’s open-access journal RMD Open concludes that exercise therapy—widely promoted as a first-line treatment for osteoarthritis—delivers, at most, small and short-term improvements in pain and function compared with placebo or no treatment, with benefits appearing smaller in larger and longer-term trials.
Raportoinut AI
Researchers at the University of Surrey have developed an AI system that predicts a patient's knee X-ray appearance one year ahead, aiding in osteoarthritis management. The tool generates visual forecasts and risk scores, presented at MICCAI 2025. It promises faster, more transparent predictions for better patient care.